Inventor · disambiguated record
Kathrin Christine Meyer
Also filed as: MEYER KATHRIN · MEYER KATHRIN CHRISTINE
1 granted patent·17 pending applications·0 citations·filing 2005–2023
14Inventor score
Top patents by PatentIndex Score
18 records- 0163US12404523B2Adeno-associated virus delivery of CLN3 polynucleotideRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Granted Sep 2, 2025·0 cites·26 claims
- 0254US2024189453A1Materials and methods for neurofibromin 2/merlin (nf2) gene therapyRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2022·Application pending·0 cites
- 0351US2022226507A1Optimized gene therapy targeting retinal cellsRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
- 0451US2025382593A1Adeno-Associated Virus Delivery of CLN1 PolynucleotideRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2023·Application pending·0 cites
- 0551US2023211018A1Materials and methods for treatment of disorders associated with the ighmbp2 geneRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
- 0648US2023090989A1AAV-Mediated Targeting of MIRNA in the Treatment of X-Linked DisordersRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2021·Application pending·0 cites
- 0747US2025002939A1Materials and methods for slc6a1 gene therapyRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2022·Application pending·0 cites
- 0846US2022202956A1Adeno-associated virus delivery of cln6 polynucleotideRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
- 0945US2023203096A1Epha4 targeting compounds and methods of use thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1045US2024189452A1Recombinant Adeno-Associated Virus Encoding Methyl-CPG Binding Protein 2 for Treating PITT Hopkins Syndrome VIA Intrathecal DeliveryRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2022·Application pending·0 cites
- 1144US2022233655A1Improved delivery of gene therapy vectors to retinal cells using a glycoside hydrolase enzymeRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
- 1240US2024060960A1Methods of predicting progression of neurological diseaseRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2022·Application pending·0 cites
- 1340US2022193259A1Gene therapy for treating or preventing visual effects in batten diseaseSANFORD RES·Filed 2020·Application pending·0 cites
- 1436US2008153925A1Use of Amphiphilic Copolymers as Solubilising AgentsBASF AG·Filed 2005·Application pending·0 cites
- 1535US2022280561A1Copper-atsm for treating neurodegenerative disorders associted with mitochondrial dysfunctionRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
- 1635US2022378945A1Gene therapy targeting cochlear cellsRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
- 1734US2022177917A1Generation of chimeric antigen receptor (car)-primary nk cells for cancer immunotherapy using a combination of cas9/rnp and aav virusesRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
- 1834US2006062847A1Pharmaceutical dosage forms with impeded extractability of a sympathomimeticBASF AG·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathrin Christine Meyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →